Safety classification systems used in dermatological medication risk counseling of pregnant and lactating patients: a case for an evidence-based approach

被引：3

作者：

Millsop, Jillian Wong ^{[1
]}

Heller, Misha M. ^{[2
]}

Murase, Jenny E. ^{[3
,4
]}

机构：

[1] Calif Pacific Med Ctr, San Francisco, CA USA

[2] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA

[3] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA

[4] Palo Alto Med Fdn Grp, Dept Dermatol, Mountain View, CA USA

来源：

DERMATOLOGIC THERAPY | 2013年 / 26卷 / 04期

关键词：

evidence-based medicine; lactation; pregnancy; risk classification; EXPOSURE; DRUGS;

D O I：

10.1111/dth.12015

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Many women of childbearing age use prescription and non-prescription medications. Therefore, patients need to be counseled regarding the potential teratogenicity of medications if they are, or could become, pregnant. In this editorial, the present authors will explain the three advantages of the evidence-based medicine system when compared with the US Food and Drug Administration system for medication risk classification in pregnancy. The present authors will also comment on medication use during lactation and provide resources on medication use during pregnancy and lactation for clinicians and their patients.

引用

页码：347 / 353

页数：7

共 28 条

[1] Risk classification systems for drug use during pregnancy - Are they a reliable source of information?
Addis, A
Sharabi, S
Bonati, M
[J]. DRUG SAFETY, 2000, 23 (03) : 245 - 253
[2] Alabdulrazzaq F, 2012, CAN FAM PHYSICIAN, V58, P643
[3] American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776
[4] Boothby LA, 2001, ANN PHARMACOTHER, V35, P1485
[5] Briggs G.G., 1994, Drugs in pregnancy and lactation, V4th
[6] Diphenhydramine overdose during pregnancy: Lessons from the past
Brost, BC
Scardo, JA
Newman, RB
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (05) : 1376 - 1377
[7] Carter JD, 2006, J RHEUMATOL, V33, P1014
[8] Data resources for investigating drug exposure during pregnancy and associated outcomes - The General Practice Research Database (GPRD) as an alternative to pregnancy registries
Charlton, Rachel A.
Cunnington, Marianne C.
de Vries, Corinne S.
Weil, John G.
[J]. DRUG SAFETY, 2008, 31 (01) : 39 - 51
[9] Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease
Cheent, Kuldeep
Nolan, Jonathan
Shariq, Sohail
Kiho, Liina
Pal, Arabinda
Arnold, Jayantha
[J]. JOURNAL OF CROHNS & COLITIS, 2010, 4 (05) : 603 - 605
[10] Evidence-based (S3) guideline on topical corticosteroids in pregnancy
Chi, C-C
Kirtschig, G.
Aberer, W.
Gabbud, J-P
Lipozencic, J.
Karpati, S.
Haustein, U-F
Zuberbier, T.
Wojnarowska, F.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (05) : 943 - 952

← 1 2 3 →